Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.240
+0.010 (0.24%)
May 1, 2026, 4:00 PM EDT - Market closed
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $153.58 million as of May 1, 2026. Its market cap has increased by 11.69% in one year.
Market Cap
153.58M
Enterprise Value
39.23M
1-Year Change
11.69%
Ranking
Category
Stock Price
$4.24
Market Cap Chart
Since the IPO on February 21, 2018, Molecular Partners AG's market cap has decreased from $595.47M to $153.58M, a decrease of -74.21%. That is a compound annual growth rate of -15.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 153.58M | -4.09% |
| Dec 30, 2025 | 160.13M | -2.96% |
| Dec 30, 2024 | 165.01M | 22.94% |
| Dec 29, 2023 | 134.22M | -38.09% |
| Dec 30, 2022 | 216.81M | -65.56% |
| Dec 30, 2021 | 629.47M | -8.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oramed Pharmaceuticals | 157.34M |
| Kazia Therapeutics | 155.86M |
| Spruce Biosciences | 154.89M |
| Galectin Therapeutics | 154.69M |
| Connect Biopharma Holdings | 152.61M |
| Tenaya Therapeutics | 151.77M |
| Alps Group | 149.76M |
| Black Diamond Therapeutics | 149.52M |